SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
21328285
Source:
http://linkedlifedata.com/resource/pubmed/id/21328285
Search
Subject
(
55
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0006826
,
umls-concept:C0030705
,
umls-concept:C0087111
,
umls-concept:C0205265
,
umls-concept:C1555582
,
umls-concept:C1861172
,
umls-concept:C2917212
pubmed:issue
2
pubmed:dateCreated
2011-2-17
pubmed:abstractText
Compared to patients without cancer, patients with cancer who receive anticoagulant treatment for venous thromboembolism are more likely to develop recurrent venous thromboembolism (VTE).
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/21328285-18254108
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21328285-21491395
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/100909747
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anticoagulants
,
http://linkedlifedata.com/resource/pubmed/chemical/Dalteparin
,
http://linkedlifedata.com/resource/pubmed/chemical/Fibrinolytic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Heparin
,
http://linkedlifedata.com/resource/pubmed/chemical/Heparin, Low-Molecular-Weight
,
http://linkedlifedata.com/resource/pubmed/chemical/Polysaccharides
,
http://linkedlifedata.com/resource/pubmed/chemical/fondaparinux
,
http://linkedlifedata.com/resource/pubmed/chemical/tinzaparin
pubmed:status
MEDLINE
pubmed:issn
1469-493X
pubmed:author
pubmed-author:AklElie AEA
,
pubmed-author:BarbaMaddalenaM
,
pubmed-author:GunukulaSameerS
,
pubmed-author:MutiPaolaP
,
pubmed-author:SchünemannHolgerH
,
pubmed-author:SperatiFrancescaF
,
pubmed-author:TerrenatoIreneI
,
pubmed-author:VasireddiSrinivasa RaoSR
pubmed:issnType
Electronic
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
CD006649
pubmed:dateRevised
2011-6-16
pubmed:meshHeading
pubmed-meshheading:21328285-Anticoagulants
,
pubmed-meshheading:21328285-Dalteparin
,
pubmed-meshheading:21328285-Fibrinolytic Agents
,
pubmed-meshheading:21328285-Heparin
,
pubmed-meshheading:21328285-Heparin, Low-Molecular-Weight
,
pubmed-meshheading:21328285-Humans
,
pubmed-meshheading:21328285-Neoplasms
,
pubmed-meshheading:21328285-Polysaccharides
,
pubmed-meshheading:21328285-Randomized Controlled Trials as Topic
,
pubmed-meshheading:21328285-Venous Thromboembolism
pubmed:year
2011
pubmed:articleTitle
Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.
pubmed:affiliation
Department of Medicine, State University of New York at Buffalo, ECMC CC-142, 462 Grider Street, Buffalo, NY, USA, 14215.
pubmed:publicationType
Journal Article
,
Review
,
Meta-Analysis